New fund­ing for Cere­nion for fur­ther devel­op­ment of the C‑Trend tech­nol­o­gy

Oulu-based health tech­nol­o­gy com­pa­ny Cere­nion has received sig­nif­i­cant fund­ing from the EU Inno­va­tion Fund and the Cen­tre for Eco­nom­ic Devel­op­ment, Trans­port and the Envi­ron­ment (ELY-keskus).

The com­pa­ny will use the fund­ing of 321,000 euros to fur­ther devel­op their C‑Trend tech­nol­o­gy as part of the Cer­eSta­tion project. The pur­pose is to devel­op inno­v­a­tive mon­i­tor­ing tools that make EEG in acute health­care eas­i­er and more acces­si­ble than ever before. The project lasts for a year, from June 2024 to June 2025. The fund­ing is main­ly used for an R&D project that brings C‑Trend to the next lev­el. 

Cere­nion is one of the most inno­v­a­tive health com­pa­nies in the Oulu region. The com­pa­ny is rev­o­lu­tion­is­ing brain mon­i­tor­ing in inten­sive care units with their inno­v­a­tive C‑Trend® tech­nol­o­gy. Cere­nion’s com­mit­ment to excel­lence is evi­dent in rig­or­ous clin­i­cal eval­u­a­tions and adher­ence to inter­na­tion­al stan­dards. The C‑Trend® tech­nol­o­gy is CE-marked as a med­ical device in Europe, under­scor­ing its safe­ty and effi­ca­cy.

Cere­nion enhances patient care through inno­v­a­tive solu­tions, which posi­tions them among lead­ers in the glob­al health tech sec­tor.

Source: Cere­nion